TSX:EXEHealthcare
Should Extendicare’s (TSX:EXE) Strong Q1 Results and Steady Dividend Policy Require Action From Investors?
Extendicare Inc. recently reported first-quarter 2026 results, with sales of C$465.22 million and net income of C$40.73 million, and its Board declared a monthly cash dividend of C$0.0441 per share for May 2026, designated as an eligible dividend under the Income Tax Act (Canada).
The sharp year-over-year rise in both revenue and earnings per share from continuing operations underscores how the business is currently converting higher sales into stronger profitability while continuing its...

